Bhupinder Bhullar has a diverse work experience in various roles and industries. Bhupinder is currently the CEO and Co-Founder of Swiss Vault Systems, a company that designs and builds cost-effective data storage systems. At Swiss Vault, they focus on disrupting the economics of data management and prioritizing data privacy.
In 2022, Bhupinder joined Zenn USA as a Manager, where they are involved in pioneering Edge Networks and developing technology to reduce the energy consumption and environmental impact of data.
Prior to these roles, Bhupinder was a Co-founder and Advisor at GeneLook, a company that helps individuals receive personalized healthcare based on their genetic predispositions. Bhupinder was also a Project Manager at DayOne Hub, Lab, Conference, an innovation program and lab for digital health innovation.
Bhupinder's earlier experience includes being an Advisory Board Member at Science Publication Network and an Advisory Board Member at Innovation Forum.
During their time at Novartis Institute For Biomedical Research (NIBR) and Novartis Pharma AG, Bhupinder served as a Laboratory Head. Bhupinder was responsible for leading research projects and managing a team.
Bhupinder's career started at Harvard Medical School, where they worked as a Postdoctoral Fellow and conducted research in the field of neuro-degeneration disorders. Bhupinder later joined Whitehead Institute, where they were a Scientist. In this role, they made significant contributions to protein aggregation modeling, implemented lab automation and high throughput screening, and developed project plans and budgets.
Overall, Bhupinder has demonstrated expertise in the fields of data storage, genetics, healthcare, digital health innovation, and biomedical research.
Bhupinder Bhullar's education history includes obtaining a Master of Business Administration (MBA) degree in Business Administration and Management, General from London Business School in 2017. Prior to this, Bhullar also pursued studies in Entrepreneurship/Entrepreneurial Studies at IMD. However, the specific start and end dates for the studies at IMD are not provided.
January, 2018 - present